Matthew Wakefield

19PUBLICATIONS

288CO-AUTHORS

Haematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targetsSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jul 08, 2026

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial.

|Nov 05, 2025

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound

|Feb 13, 2025

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Takafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu

|Jan 31, 2024

The role of aberrant DNA methylation in cancer initiation and clinical impacts.

Franziska Geissler, Ksenija Nesic, Olga Kondrashova

|Nov 29, 2023

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.

Gwo Yaw Ho, Cassandra J Vandenberg, Ratana Lim

|Aug 16, 2023

Interferon-ε is a tumour suppressor and restricts ovarian cancer.

Zoe R C Marks, Nicole K Campbell, Niamh E Mangan

Pageof 4

Frequent Collaborators

Clare L Scott

Gwo-Yaw Ho

Olga Kondrashova

Anna DeFazio

Anthony T Papenfuss

Iain A McNeish

Cassandra J Vandenberg

3 joint publications

Kylie L Gorringe

3 joint publications

Scott H Kaufmann

3 joint publications

Justin Bedo

Frequent Collaborators

Clare L Scott

Gwo-Yaw Ho

Olga Kondrashova

Anna DeFazio